HK1020952A1 - Polymorphs (iii) of donepezil hydrochloride and preparation processe and use thereof. - Google Patents

Polymorphs (iii) of donepezil hydrochloride and preparation processe and use thereof.

Info

Publication number
HK1020952A1
HK1020952A1 HK99106107A HK99106107A HK1020952A1 HK 1020952 A1 HK1020952 A1 HK 1020952A1 HK 99106107 A HK99106107 A HK 99106107A HK 99106107 A HK99106107 A HK 99106107A HK 1020952 A1 HK1020952 A1 HK 1020952A1
Authority
HK
Hong Kong
Prior art keywords
processe
polymorphs
iii
preparation
donepezil hydrochloride
Prior art date
Application number
HK99106107A
Other languages
English (en)
Inventor
Akio Imai
Hideaki Watanabe
Takashi Kajima
Yasushi Ishihama
Akiyo Ohtsuka
Tomohide Tanaka
Yukio Narabu
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1996/003881 external-priority patent/WO1997046526A1/en
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of HK1020952A1 publication Critical patent/HK1020952A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK99106107A 1996-06-07 1999-12-24 Polymorphs (iii) of donepezil hydrochloride and preparation processe and use thereof. HK1020952A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP14629396 1996-06-07
PCT/JP1996/003881 WO1997046526A1 (en) 1996-06-07 1996-12-27 Stable polymorphs of donepezil (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine) hydrochloride and process for production
US08/774,802 US6140321A (en) 1996-06-07 1996-12-30 Polymorphs of donepezil hydrochloride and process for production
PCT/JP1997/001932 WO1997046527A1 (en) 1996-06-07 1997-06-06 Polymorphs of donepezil hydrochloride and process for production

Publications (1)

Publication Number Publication Date
HK1020952A1 true HK1020952A1 (en) 2000-05-26

Family

ID=27307991

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99106107A HK1020952A1 (en) 1996-06-07 1999-12-24 Polymorphs (iii) of donepezil hydrochloride and preparation processe and use thereof.

Country Status (12)

Country Link
EP (2) EP1019374B1 (de)
AU (1) AU731282B2 (de)
CA (1) CA2252806C (de)
DK (1) DK1019374T3 (de)
ES (1) ES2188946T3 (de)
HK (1) HK1020952A1 (de)
NO (1) NO321267B1 (de)
NZ (1) NZ333197A (de)
RU (1) RU2190603C2 (de)
SI (1) SI9720038B (de)
SK (1) SK285312B6 (de)
WO (1) WO1997046527A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE241358T1 (de) 1997-03-03 2003-06-15 Eisai Co Ltd Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen
GB9716879D0 (en) * 1997-08-08 1997-10-15 Shire Int Licensing Bv Treatment of attention deficit disorders
ATE260896T1 (de) 1997-12-05 2004-03-15 Eisai Co Ltd Donepezil polykristalle und verfharen zu ihrer herstellung
US6193993B1 (en) * 1998-03-03 2001-02-27 Eisai Co., Ltd. Suppository containing an antidementia medicament
PL346242A1 (en) * 1998-06-16 2002-01-28 Lilly Co Eli Methods for increasing levels of acetylcholine
TR200003704T2 (tr) 1998-06-16 2001-06-21 Eli Lilly And Company Asetilkolin düzeylerini arttırma
US6288108B1 (en) 1998-06-16 2001-09-11 Eli Lilly And Company Methods for increasing levels of acetylcholine
PT1311272E (pt) 2000-03-03 2007-02-28 Eisai R&D Man Co Ltd Novos métodos utilizando inibidores de colinesterase
SI21223A (sl) * 2002-06-19 2003-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Farmacevtska formulacija s stabiliziranim amorfnim donepezilijevim kloridom
IL150509A (en) 2002-07-01 2007-07-04 Joseph Kaspi Pharmaceutical preparations containing donafazil hydrochloride
AU2003287433A1 (en) * 2002-11-01 2004-06-07 Oregon Health And Science University Treatment of hyperkinetic movement disorder with donepezil
US7186842B2 (en) 2003-02-12 2007-03-06 Usv, Ltd. Polymorph of (1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-y1] methyl piperidine hydrochloride (Donepezil hydrochloride) and a process for producing thereof
US20050288330A1 (en) * 2004-06-29 2005-12-29 Avinash Naidu Process for producing a polymorphic form of (1-Benzyl-4-[(5,6-dimethoxy-1-indanone)-2-yl] methyl piperidine hydrochloride (donepezil hydrochloride)
WO2004092137A1 (en) * 2003-04-16 2004-10-28 Hetero Drugs Limited Novel crystalline forms of donepezil hydrochloride
EP1771416A1 (de) * 2004-07-28 2007-04-11 USV Limited Neuer polymorph von (1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidinhydrochlorid (donepezilhydrochlorid) und verfahren zu dessen herstellung
WO2006015338A2 (en) * 2004-07-30 2006-02-09 Dr. Reddy's Laboratories Ltd. Crystalline form of donepezil hydrochloride
RS51271B (sr) * 2004-10-19 2010-12-31 Krka Tovarna Zdravil D.D. Čvrsta farmaceutska kompozicija koja sadrži donepezil hidrohlorid
EP1858847A1 (de) * 2005-02-28 2007-11-28 Ranbaxy Laboratories Limited Stabiles form-i-donepezilhydrochlorid und verfahren zu dessen herstellung und dessen verwendung in pharmazeutischen zusammensetzungen
WO2006097341A1 (en) * 2005-03-17 2006-09-21 Synthon B.V. Process for making crystalline donepezil hydrochloride monohydrate
WO2006111983A2 (en) * 2005-04-21 2006-10-26 Jubilant Organosys Limited NOVEL POLYMORPHIC FORM OF (l-BENZYL-4-[(5,6-DIMETHOXY-l- INDANONE)-2-YL]METHYL PIPERIDINE HYDROCHLORIDE AND PROCESS FOR PREPARING THE SAME
GB0515803D0 (en) * 2005-07-30 2005-09-07 Pliva Hrvatska D O O Intermediate compounds
HU227474B1 (en) * 2005-12-20 2011-07-28 Richter Gedeon Nyrt Process for industrial scale production of high purity donepezil hydrochloride polymorph i.
SI2032521T1 (sl) 2006-06-27 2010-02-26 Sandoz Ag Nov postopek za pripravo soli
US8247563B2 (en) 2006-12-11 2012-08-21 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
DE102007037932A1 (de) 2007-08-11 2009-02-12 Alfred E. Tiefenbacher Gmbh & Co.Kg Donepezilhydrochlorid in amorpher Form enthaltende Tablette
CN102603612A (zh) * 2007-09-28 2012-07-25 天津和美生物技术有限公司 多奈哌齐盐的多晶型物及其制备和应用
JP5562337B2 (ja) * 2008-12-17 2014-07-30 エーザイ・アール・アンド・ディー・マネジメント株式会社 ドネペジルの多形結晶及びその製造方法
DE102010010998A1 (de) 2010-03-10 2011-09-15 Stada Arzneimittel Ag Feste pharmazeutische Zusammensetzung, umfassend Donepezil-Hydrochlorid der kristallinen polymorphen Form I
WO2011151359A1 (en) 2010-06-02 2011-12-08 Noscira, S.A. Combined treatment with a cholinesterase inhibitor and a thiadiazolidinedione derivative
EP2502620A1 (de) 2011-03-24 2012-09-26 Krka Tovarna Zdravil, D.D., Novo Mesto Feste pharmazeutische Zusammensetzung mit Donepezil
CN110393440B (zh) * 2019-06-28 2021-08-13 顾美红 一种即热式烧水机

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi

Also Published As

Publication number Publication date
SI9720038A (sl) 1999-06-30
NO321267B1 (no) 2006-04-10
NO985721L (no) 1999-01-28
SI9720038B (sl) 2010-06-30
NO985721D0 (no) 1998-12-07
SK167698A3 (en) 1999-06-11
EP1211243B1 (de) 2009-10-14
SK285312B6 (sk) 2006-10-05
EP1211243A1 (de) 2002-06-05
WO1997046527A1 (en) 1997-12-11
DK1019374T3 (da) 2003-04-07
RU2190603C2 (ru) 2002-10-10
ES2188946T3 (es) 2003-07-01
EP1019374B1 (de) 2003-01-02
AU731282B2 (en) 2001-03-29
CA2252806A1 (en) 1997-12-11
NZ333197A (en) 2001-03-30
CA2252806C (en) 2005-11-22
AU2979297A (en) 1998-01-05
EP1019374A1 (de) 2000-07-19

Similar Documents

Publication Publication Date Title
HK1020952A1 (en) Polymorphs (iii) of donepezil hydrochloride and preparation processe and use thereof.
GB2310601B (en) Paracetamol sustained-release formulation
PL330990A1 (en) Improved method of halogenating isomo-olefinic copolymers
PL317930A1 (en) Oxalydine compounds, method of obtaining them and therapeutic agents
HUP0003449A3 (en) New block copolymers and preparation thereof
PL328074A1 (en) Therapeutical method and pharmaceutic composition
HUP9700446A3 (en) Oilsuspension-concentrate and using thereof
GB9605236D0 (en) Blender
HK1021117A1 (en) Candy-toy and method thereof
IL130125A (en) Preparation of n-substituted 3-hydroxypyrazoles
AU130514S (en) Blender
PL319451A1 (en) Method of obtaining titanium oxide
GB9610501D0 (en) Method of scanning
EP0760823A4 (de) KLONIERTES ÄUSSERES MEMBRANPROTEIN AUS -i(LEPTOSPIRA)
PL345068A1 (en) Novel compounds derived from α-d-xylose, preparation method and therapeutic use
PL328334A1 (en) Preparation and application thereof
HK1020963A1 (en) Preparation of 1-butyl-4-piperidinylmethylamine
GB9716606D0 (en) Keypad arrangement and method of manufacture thereof
ZA9711669B (en) Cyanophosphorus compounds and their preparation
PL322543A1 (en) Method of obtaining dexphenyl fluramine hydrochloride
ZA971483B (en) Pure somatostatin antagonist and methods for use thereof
GB9718159D0 (en) Preparation and Use of Potential-Controlled Membranes
TW295208U (en) Connection structure of rowed nail
SI0902777T1 (en) D-mannitol and its preparation
TW309986U (en) Improved structure of urn

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20170605